Green Lifescience그린생명과학
114450 · KOSDAQ · ₩114450 · 그린생명과학
₩2,130▼ ₩30 (1.39%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 10.3% | 6.1% | 12.0% | −10.3% | −3.7% | −9.0% |
| Operating margin | 6.3% | 0.5% | 1.5% | −20.8% | −10.8% | −18.3% |
| Net margin | 7.6% | 0.3% | 6.3% | −73.1% | −9.7% | −12.4% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +45.2% | +62.3% | +11.1% | −38.7% | +44.1% | — |
| Operating income growth | +1,718.8% | −45.8% | +108.1% | −17.3% | +14.8% | — |
| Net income growth | +3,944.7% | −92.9% | +109.5% | −364.0% | −12.4% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 10.7% | 0.3% | 4.4% | −36.9% | −6.5% | −5.6% |
| Return on assets | 7.8% | 0.2% | 3.5% | −30.8% | −5.2% | −4.4% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 32.3% | 43.3% | 25.8% | 21.9% | 18.6% | 27.8% |
| Net debt to equity | −19.5% | −18.1% | −12.3% | −26.8% | −1.3% | −1.7% |
| Current ratio | 290.7% | 204.1% | 264.5% | 293.7% | 280.2% | 176.4% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Green Lifescience / 그린생명과학 / 114450 / KRX:114450
Source: KRX statistical information